The trend toward biologics development in the United States has been apparent. The total number of reported clinical trials with a biological intervention between 2000 and 2005 was 1,197. In the follo
discussing data, opportunities and prospects. This study investigates biosimilars (follow-on biologics). It lets you assess forecasted sales at world market, therapeutic submarket and nationa...